Search Results

Insights into CCBs and pancreatic cancer presented at American Association for Cancer Research Annual Meeting, Chicago, IL, US, April 14–18, 2018. Pancreatic cancer will be responsible for approximately 44,330 deaths in 2018 in the US, according to the American Cancer Society (ACS).1 It is one of the most feared malignancies because of its dismal prognosis; […]

While targeted therapies and immune checkpoint inhibitors have grabbed the headlines at recent oncology conferences, it is important to remember that early diagnosis is key to successful cancer treatment. The liquid biopsy—a blood test that detects early stage cancer—has long remained the Holy Grail of cancer screening and diagnosis. Genetic testing for specific mutations in […]

Pancreatic cancer is one of the most difficult cancers to treat, and is still considered incurable. The one-year relative survival rate is 20% and the five-year survival rate is 9%, the lowest of any solid tumour.1 These low rates reflect the fact that more than 80% of tumours have spread beyond the pancreas at the […]

Prostate cancer is the second most common cancer in men and the fourth most commonly occurring cancer worldwide, with 1.3 million new cases in 2018.1 Prostate cancer is considered to be castrate-sensitive (castration-sensitive prostate cancer [CSPC]) if it responds to medical or surgical treatment to lower a patient’s testosterone levels. Androgen-deprivation therapy (ADT) has been […]

Ovarian cancer is a leading cause of cancer death in women worldwide, with almost 300,000 cases diagnosed in 2018.1 If diagnosed and treated at stage I, the 5-year relative survival rate is 92%. However, only about 15% of ovarian cancers are diagnosed at this stage, and the prognosis for advanced ovarian cancer is bleak: 5-year […]